Peter Lindsay, a partner in our FDA Regulatory & Enforcement practice, is proud to speak at FDLI’s Enforcement, Litigation and Compliance Conference taking place virtually on December 9-10, 2021.

Peter will be speaking on a panel with Elizabeth Miller, Assistant Commissioner Medical Products and Tobacco Operations, Office of Regulatory Affairs at the FDA, and Stephanie M. Haggerty, Senior Corporate Counsel at Pfizer Inc., about the “Continuing Impact of FDA’s Inspection Approach on Industry and What Happens Next”.  Cathy L. Burgess, a Partner at Alston & Bird LLP and Member of the FDLI Board of Directors, will moderate the session.

For more information and to register, visit the FDLI website here.